Martin J Middleditch

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 6

Top Topics

Mycobacterium Tuberculosis

Top Venues

Biomacromolecules

Acta crystallographica. Section D, Structural biology

This page only lists publications with an associated author ORCID identifier.

Publications

Paul G Young, Jacob M Paynter, Julia K Wardega, Martin J Middleditch, Leo S Payne, Edward N Baker, Christopher J Squire
Domain structure and cross-linking in a giant adhesin from the Mobiluncus mulieris bacterium. Acta crystallographica. Section D, Structural biology (2023)
Minsoo Yoon, Martin J Middleditch, Erik H A Rikkerink
A conserved glutamate residue in RPM1-INTERACTING PROTEIN4 is ADP-ribosylated by the Pseudomonas effector AvrRpm2 to activate RPM1-mediated plant resistance. The Plant cell 34 (12) (2022)
Yue Wang, Ries J Langley, Kyle Tamshen, Julia Harms, Martin J Middleditch, Heather D Maynard, Stephen M F Jamieson, Jo K Perry
Enhanced Bioactivity of a Human GHR Antagonist Generated by Solid-Phase Site-Specific PEGylation. Biomacromolecules 22 (2) (2020)
Brooke X C Kwai, Annabelle J Collins, Martin J Middleditch, Jonathan Sperry, Ghader Bashiri, Ivanhoe K H Leung
Itaconate is a covalent inhibitor of the Mycobacterium tuberculosis isocitrate lyase. RSC medicinal chemistry 12 (1) (2020)
Danilo Correddu, José de Jesús Montaño López, S Andreas Angermayr, Martin J Middleditch, Leo S Payne, Ivanhoe K H Leung
Effect of consecutive rare codons on the recombinant production of human proteins in Escherichia coli. IUBMB life 72 (2) (2019)
Maria Kalyukina, Yuliana Yosaatmadja, Martin J Middleditch, Adam V Patterson, Jeff B Smaill, Christopher J Squire
TAS-120 Cancer Target Binding: Defining Reactivity and Revealing the First Fibroblast Growth Factor Receptor 1 (FGFR1) Irreversible Structure. ChemMedChem 14 (4) (2019)